Terms: = Endocrine gland cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL
209 results:
1. [Applications of Artificial Intelligence in Pancreatic Cystic Lesion Imaging].
Deng WY; Xie FY; Xue HD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Apr; 46(2):275-280. PubMed ID: 38686726
[TBL] [Abstract] [Full Text] [Related]
2. Neutrophil Gelatinase-Associated Lipocalin for the Differentiation of Mucinous Pancreatic Cystic Lesions.
Olar MP; Iacobescu M; Bolboacă SD; Pojoga C; Moșteanu O; Seicean R; Rusu I; Banc O; Iuga CA; Seicean A
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542201
[TBL] [Abstract] [Full Text] [Related]
3. Characterisation of the cell and molecular biological effect of peptide-based daunorubicin conjugates developed for targeting pancreatic adenocarcinoma (PANC-1) cell line.
Szász Z; Enyedi KN; Takács A; Fekete N; Mező G; Kőhidai L; Lajkó E
Biomed Pharmacother; 2024 Apr; 173():116293. PubMed ID: 38430628
[TBL] [Abstract] [Full Text] [Related]
4. Biomarker Testing Journey Among Patients with Advanced Solid Tumors and Treatment Patterns by Homologous Recombination Repair Status: A Clinico-Genomic Database Study.
Shao C; Ren Y; Zhou H; Lee LC; Chen C; Dettman EJ; Cristescu R; Gozman A; Jin F; Zhou W
Adv Ther; 2024 Feb; 41(2):759-776. PubMed ID: 38169059
[TBL] [Abstract] [Full Text] [Related]
5. An integrated analysis identifies six molecular subtypes of pancreatic ductal adenocarcinoma revealing cellular and molecular landscape.
Li L; Shen L; Wu H; Li M; Chen L; Zhou Q; Ma J; Huai C; Zhou W; Wei M; Zhao M; Zhao X; Du H; Jiang B; Sun Y; Zhang N; Qin S; Xing T
Carcinogenesis; 2023 Dec; 44(10-11):726-740. PubMed ID: 37747815
[TBL] [Abstract] [Full Text] [Related]
6. Hashimoto's thyroiditis is negatively associated with lymph node metastasis in PTMC.
Huang H; Xu S; Ni S; Liu W; Liu S
J Cancer Res Clin Oncol; 2023 Nov; 149(17):15525-15533. PubMed ID: 37646829
[TBL] [Abstract] [Full Text] [Related]
7. Potential impact of obesity on the aggressiveness of low- to intermediate-risk papillary thyroid carcinoma: results from a MASTER cohort study.
Kim M; Kang YE; Park YJ; Koo BS; Ku EJ; Choi JY; Lee EK; Kim BH
Endocrine; 2023 Oct; 82(1):134-142. PubMed ID: 37516686
[TBL] [Abstract] [Full Text] [Related]
8. Pancreatic Cyst Surveillance: Who, Why, How?
Luk L; Lowy AM; Li K; Fowler KJ; Wang ZJ; Kamel IR; Liau J
Radiology; 2023 Jul; 308(1):e222778. PubMed ID: 37489987
[TBL] [Abstract] [Full Text] [Related]
9. Endoscopic Imaging of Pancreatic Cysts.
Al-Taee AM; Taylor JR
Gastrointest Endosc Clin N Am; 2023 Jul; 33(3):583-598. PubMed ID: 37245937
[TBL] [Abstract] [Full Text] [Related]
10. Anticancer Evaluation of Methoxy Poly(Ethylene Glycol)-
Shin YB; Choi JY; Shin DH; Lee JW
Int J Nanomedicine; 2023; 18():2209-2223. PubMed ID: 37152471
[TBL] [Abstract] [Full Text] [Related]
11. The Natural History of Pancreatic Cystic Lesions in Liver Transplant Recipients: A Systematic Review and Meta-analysis.
Canakis A; Vittal A; Deliwala S; Twery B; Canakis J; Patel P; Chahal P
Pancreas; 2022 Oct; 51(9):1160-1166. PubMed ID: 37078940
[TBL] [Abstract] [Full Text] [Related]
12. vegfr3 suppression through miR-1236 inhibits proliferation and induces apoptosis in ovarian cancer via ERK1/2 and AKT signaling pathways.
Babaei Z; Panjehpour M; Ghorbanhosseini SS; Parsian H; Khademi M; Aghaei M
J Cell Biochem; 2023 May; 124(5):674-686. PubMed ID: 36922713
[TBL] [Abstract] [Full Text] [Related]
13. Molecular mechanisms of miR-1236 in the assessment of tumor lymphangiogenesis in human ovarian cancer patients.
Khademi M; Babaei Z; Ghorbanhosseini SS; Emami Razavi A; Aghaei M
J Gene Med; 2023 May; 25(5):e3480. PubMed ID: 36750632
[TBL] [Abstract] [Full Text] [Related]
14. Surgical treatment for pancreatic cystic lesions-implications from the multi-center and prospective German StuDoQ|Pancreas registry.
Henn J; Wyzlic PK; Esposito I; Semaan A; Branchi V; Klinger C; Buhr HJ; Wellner UF; Keck T; Lingohr P; Glowka TR; Manekeller S; Kalff JC; Matthaei H;
Langenbecks Arch Surg; 2023 Jan; 408(1):28. PubMed ID: 36640188
[TBL] [Abstract] [Full Text] [Related]
15. Comparative Performance of Endoscopic Ultrasound-Based Techniques in Patients With Pancreatic Cystic Lesions: A Network Meta-Analysis.
Li SY; Wang ZJ; Pan CY; Wu C; Li ZS; Jin ZD; Wang KX
Am J Gastroenterol; 2023 Feb; 118(2):243-255. PubMed ID: 36563321
[TBL] [Abstract] [Full Text] [Related]
16. Diagnosis of a cystic pancreatic neuroendocrine tumor: is cystic fluid chromogranin A useful?
Marín Serrano E; Duque Alcorta M
Rev Esp Enferm Dig; 2023 Sep; 115(9):526-527. PubMed ID: 36454060
[TBL] [Abstract] [Full Text] [Related]
17. PDAC-on-chip for
Sgarminato V; Marasso SL; Cocuzza M; Scordo G; Ballesio A; Ciardelli G; Tonda-Turo C
Biomater Sci; 2022 Dec; 11(1):208-224. PubMed ID: 36420859
[TBL] [Abstract] [Full Text] [Related]
18. Accurate Identification of Mucinous Pancreatic Cystic Lesions Using Small-Volume Analytes.
Caiazza F; Conroy PC; Ivry SL; York T; Lin J; Hernandez S; Hoffmann TJ; Francis SS; Park WG; Yip-Schneider MT; Schmidt CM; Brand R; Craik CS; Kirkwood K
J Surg Res; 2023 Apr; 284():322-331. PubMed ID: 36369049
[TBL] [Abstract] [Full Text] [Related]
19. PTEN regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated vegfr3 dephosphorylation.
Chang TM; Chu PY; Lin HY; Huang KW; Hung WC; Shan YS; Chen LT; Tsai HJ
J Biomed Sci; 2022 Nov; 29(1):92. PubMed ID: 36336681
[TBL] [Abstract] [Full Text] [Related]
20. Pancreatic Cystic Lesions: Review of the Current State of Diagnosis and Surveillance.
Alwahbi O; Ghumman Z; van der Pol CB; Patlas MN; Gopee-Ramanan P
Can Assoc Radiol J; 2023 Aug; 74(3):557-569. PubMed ID: 36220377
[TBL] [Abstract] [Full Text] [Related]
[Next]
